This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

INCY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,787,827.45

Incyte Insider Trading History Chart

Incyte Share Price & Price History

^$75.87

▼ -1.86 (-2.39%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Get Your Free Gold Guide

Incyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2024	Barry P Flannelly	EVP	Sell	3,680	$79.68	$293,222.40	58,042
9/12/2024	Jonathan Elliott Dickinson	EVP	Sell	8,450	$62.36	$526,942.00	36,390
9/12/2024	Thomas Tray	Insider	Sell	572	$62.94	$36,001.68	24,825
7/25/2024	Vijay K. Iyengar	EVP	Sell	15,571	$70.00	$1,089,970.00	36,701
7/16/2024	Barry P Flannelly	EVP	Sell	1,306	$64.19	$83,832.14	58,042
7/9/2024	Barry P Flannelly	EVP	Sell	8,148	$60.00	$488,880.00	50,534
6/12/2024	Barry P Flannelly	EVP	Sell	19,164	$60.00	$1,149,840.00	66,377
6/6/2024	Thomas Tray	Insider	Sell	1,093	$58.91	$64,388.63	21,634
1/2/2024	Vijay K. Iyengar	EVP	Sell	657	$65.00	$42,705.00	43,412
12/12/2023	Thomas Tray	Insider	Sell	210	$57.36	$12,045.60	24,503
1/30/2023	Maria E. Pasquale	EVP	Sell	60,024	$84.74	$5,086,433.76	68,524
1/26/2023	Vijay K. Iyengar	EVP	Sell	7,000	$85.00	$595,000.00	42,835
1/4/2023	Steven H. Stein	EVP	Sell	28,399	$79.78	$2,265,672.22	109,021
12/23/2022	Vijay K. Iyengar	EVP	Sell	17,324	$80.80	$1,399,779.20	37,855
12/19/2022	Thomas Tray	Insider	Sell	1,223	$82.16	$100,481.68	16,606
7/22/2022	Thomas Tray	Insider	Sell	1,564	$83.13	$130,015.32	17,702
7/7/2022	Vijay K. Iyengar	EVP	Sell	5,787	$79.38	$459,372.06	40,313
4/8/2022	Barry P Flannelly	EVP	Sell	43,993	$83.49	$3,672,975.57	65,163
3/10/2022	Bros. Advisors Lp Baker	Director	Buy	218,563	$73.13	$15,983,512.19
3/8/2022	Bros. Advisors Lp Baker	Director	Buy	100,000	$70.67	$7,067,000.00
2/22/2022	Bros. Advisors Lp Baker	Director	Buy	99,800	$68.07	$6,793,386.00
2/17/2022	Bros. Advisors Lp Baker	Director	Buy	292,972	$67.74	$19,845,923.28
1/31/2022	Jonathan Elliott Dickinson	EVP	Sell	7,375	$74.19	$547,151.25
1/7/2022	Paula J. Swain	EVP	Sell	10,870	$73.31	$796,879.70
12/23/2021	Wendy L. Dixon	Director	Sell	20,000	$22.05	$441,000.00
12/17/2021	Bros. Advisors Lp Baker	Director	Buy	1,075,872	$72.80	$78,323,481.60
12/15/2021	Bros. Advisors Lp Baker	Director	Buy	350,332	$71.51	$25,052,241.32

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

SEC Filings (Institutional Ownership Changes) for Incyte (NASDAQ:INCY)

96.97% of Incyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Incyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	3,936,176	$259.33M	0.0%	-2.7%	2.043%
11/15/2024	Vestcor Inc	2,625	$0.17M	0.0%	-86.7%	0.001%
11/15/2024	M&T Bank Corp	11,872	$0.79M	0.0%	-1.3%	0.006%
11/15/2024	Barclays PLC	1,031,932	$68.21M	0.0%	+8.1%	0.536%
11/15/2024	Continuum Advisory LLC	580	$38K	0.0%	-98.9%	0.000%
11/15/2024	Public Employees Retirement System of Ohio	58,971	$3.90M	0.0%	-17.9%	0.031%
11/15/2024	Groupama Asset Managment	59,597	$39K	0.0%	+11.4%	0.031%
11/15/2024	Nomura Asset Management Co. Ltd.	76,955	$5.09M	0.0%	+14.4%	0.040%
11/15/2024	MML Investors Services LLC	6,063	$0.40M	0.0%	+4.4%	0.003%
11/15/2024	Orion Portfolio Solutions LLC	11,655	$0.77M	0.0%	N/A	0.006%
11/15/2024	XTX Topco Ltd	22,057	$1.46M	0.1%	-29.0%	0.011%
11/15/2024	National Bank of Canada FI	81,728	$5.40M	0.0%	+86.1%	0.042%
11/15/2024	EP Wealth Advisors LLC	5,628	$0.37M	0.0%	+42.1%	0.003%
11/15/2024	Wellington Management Group LLP	71,730	$4.74M	0.0%	-59.0%	0.037%
11/15/2024	State Street Corp	10,551,279	$697.44M	0.0%	-2.8%	5.477%
11/15/2024	Quantinno Capital Management LP	67,968	$4.49M	0.1%	+106.5%	0.035%
11/15/2024	Royal London Asset Management Ltd.	174,689	$11.55M	0.0%	-4.5%	0.091%
11/15/2024	Point72 DIFC Ltd	49,921	$3.30M	0.1%	N/A	0.026%
11/15/2024	Point72 Asset Management L.P.	2,369,300	$156.61M	0.4%	N/A	1.230%
11/15/2024	Invenomic Capital Management LP	88,752	$5.87M	0.3%	-16.5%	0.046%
11/15/2024	Investment Management Corp of Ontario	26,880	$1.78M	0.0%	+4.7%	0.014%
11/15/2024	Itau Unibanco Holding S.A.	974	$64K	0.0%	+63.4%	0.001%
11/15/2024	Jacobs Levy Equity Management Inc.	92,782	$6.13M	0.0%	-40.3%	0.048%
11/15/2024	Janus Henderson Group PLC	171,129	$11.31M	0.0%	-6.3%	0.089%
11/15/2024	HighTower Advisors LLC	209,703	$13.85M	0.0%	-0.3%	0.109%
11/15/2024	Centiva Capital LP	6,253	$0.41M	0.0%	-34.7%	0.003%
11/15/2024	Chevy Chase Trust Holdings LLC	85,709	$5.67M	0.0%	-1.3%	0.044%
11/15/2024	Concentric Capital Strategies LP	69,369	$4.59M	0.2%	N/A	0.036%
11/15/2024	Atom Investors LP	4,691	$0.31M	0.0%	-36.1%	0.002%
11/15/2024	Baker BROS. Advisors LP	30,739,020	$2.03B	21.1%	+0.0%	15.956%
11/15/2024	Paloma Partners Management Co	7,000	$0.46M	0.0%	-15.7%	0.004%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	500	$33K	0.0%	N/A	0.000%
11/15/2024	Point72 Hong Kong Ltd	2,946	$0.20M	0.0%	N/A	0.002%
11/15/2024	Erste Asset Management GmbH	51,200	$3.37M	0.0%	N/A	0.027%
11/14/2024	Bellevue Group AG	2,150,551	$142.15M	2.3%	-0.1%	1.116%
11/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	27,158	$1.80M	0.0%	-9.9%	0.014%
11/14/2024	Edgestream Partners L.P.	22,408	$1.48M	0.1%	N/A	0.012%
11/14/2024	Point72 Europe London LLP	90,397	$5.98M	0.4%	N/A	0.047%
11/14/2024	Caisse DE Depot ET Placement DU Quebec	5,002	$0.33M	0.0%	-98.5%	0.003%
11/14/2024	PDT Partners LLC	4,734	$0.31M	0.0%	-42.7%	0.002%
11/14/2024	Verition Fund Management LLC	40,467	$2.68M	0.0%	N/A	0.021%
11/14/2024	Captrust Financial Advisors	5,784	$0.38M	0.0%	-21.5%	0.003%
11/14/2024	Rockefeller Capital Management L.P.	41,868	$2.77M	0.0%	-0.4%	0.022%
11/14/2024	Martingale Asset Management L P	3,692	$0.24M	0.0%	-5.3%	0.002%
11/14/2024	Northwest & Ethical Investments L.P.	30,764	$2.03M	0.1%	-17.4%	0.016%
11/14/2024	Vinva Investment Management Ltd	12,108	$0.80M	0.0%	-70.1%	0.006%
11/14/2024	Public Sector Pension Investment Board	6,622	$0.44M	0.0%	+4.7%	0.003%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,379,465	$91.18M	0.0%	-24.1%	0.716%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	160,415	$10.60M	0.0%	+30.1%	0.083%
11/14/2024	MetLife Investment Management LLC	41,973	$2.77M	0.0%	-3.3%	0.022%
11/14/2024	CreativeOne Wealth LLC	6,915	$0.46M	0.0%	N/A	0.004%
11/13/2024	Clark Estates Inc. NY	54,150	$3.58M	0.7%	-7.5%	0.028%
11/13/2024	Glenmede Trust Co. NA	697,025	$46.07M	0.2%	-18.4%	0.362%
11/13/2024	Bridgewater Associates LP	308,632	$20.40M	0.1%	+142.8%	0.160%
11/13/2024	Freedom Investment Management Inc.	16,092	$1.06M	0.1%	N/A	0.008%
11/13/2024	CKW Financial Group	800	$54K	0.0%	-20.0%	0.000%
11/13/2024	BNP Paribas Financial Markets	184,804	$12.22M	0.0%	-7.8%	0.096%
11/13/2024	Brooklyn Investment Group	454	$30K	0.0%	N/A	0.000%
11/13/2024	Quantbot Technologies LP	5,450	$0.36M	0.0%	-55.6%	0.003%
11/13/2024	D.A. Davidson & CO.	3,225	$0.21M	0.0%	-7.2%	0.002%
11/13/2024	FMR LLC	1,320,469	$87.28M	0.0%	-26.1%	0.685%
11/13/2024	Patton Albertson Miller Group LLC	78,743	$5.21M	0.7%	-4.7%	0.041%
11/13/2024	The Manufacturers Life Insurance Company	165,537	$10.94M	0.0%	+33.3%	0.086%
11/13/2024	Bank of Montreal Can	194,736	$12.82M	0.0%	-10.6%	0.101%
11/13/2024	Dynamic Technology Lab Private Ltd	5,059	$0.33M	0.0%	-70.9%	0.003%
11/13/2024	Fisher Asset Management LLC	11,522	$0.76M	0.0%	+24.5%	0.006%
11/13/2024	Daiwa Securities Group Inc.	20,649	$1.37M	0.0%	-4.9%	0.011%
11/12/2024	Summit Trail Advisors LLC	5,470	$0.36M	0.0%	N/A	0.003%
11/12/2024	Cerity Partners LLC	19,157	$1.27M	0.0%	+40.7%	0.010%
11/12/2024	Great Valley Advisor Group Inc.	5,903	$0.39M	0.0%	-11.9%	0.003%
11/12/2024	Citigroup Inc.	166,550	$11.01M	0.0%	-42.8%	0.086%
11/12/2024	Charles Schwab Investment Management Inc.	1,609,220	$106.37M	0.0%	+29.2%	0.835%
11/12/2024	Banco Santander S.A.	94,418	$6.24M	0.1%	-20.4%	0.049%
11/12/2024	Blackhawk Capital Partners LLC.	4,812	$0.32M	0.2%	-62.5%	0.002%
11/12/2024	Massachusetts Financial Services Co. MA	71,691	$4.74M	0.0%	N/A	0.037%
11/9/2024	Cypress Capital Group	14,695	$0.97M	0.1%	N/A	0.008%
11/9/2024	Intech Investment Management LLC	62,256	$4.12M	0.0%	-41.4%	0.032%
11/8/2024	Grandfield & Dodd LLC	19,525	$1.29M	0.1%	+3.2%	0.010%
11/8/2024	Advisors Asset Management Inc.	15,244	$1.01M	0.0%	+2.6%	0.008%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	582,107	$38.48M	0.2%	-48.5%	0.302%
11/8/2024	Commerce Bank	9,221	$0.61M	0.0%	N/A	0.005%
11/8/2024	Northwest Bancshares Inc.	66,434	$4.39M	0.7%	-7.6%	0.034%
11/8/2024	PNC Financial Services Group Inc.	30,649	$2.03M	0.0%	+42.1%	0.016%
11/8/2024	B. Metzler seel. Sohn & Co. Holding AG	4,421	$0.29M	0.0%	N/A	0.002%
11/8/2024	Banque Cantonale Vaudoise	8,730	$0.58M	0.0%	+336.1%	0.005%
11/8/2024	Princeton Capital Management LLC	4,098	$0.27M	0.1%	-43.9%	0.002%
11/8/2024	Prospera Financial Services Inc	3,788	$0.25M	0.0%	-43.5%	0.002%
11/7/2024	Meeder Asset Management Inc.	2,811	$0.19M	0.0%	N/A	0.001%
11/7/2024	Quest Partners LLC	2,284	$0.15M	0.0%	-67.0%	0.001%
11/7/2024	TrinityPoint Wealth LLC	20,638	$1.36M	0.2%	+3.4%	0.011%
11/7/2024	Swiss National Bank	483,274	$31.94M	0.0%	+0.9%	0.251%
11/7/2024	Thrivent Financial for Lutherans	7,332	$0.49M	0.0%	-1.9%	0.004%
11/7/2024	AM Squared Ltd	1,800	$0.12M	0.3%	+125.0%	0.001%
11/6/2024	Mutual of America Capital Management LLC	19,729	$1.30M	0.0%	-2.9%	0.010%
11/6/2024	Seizert Capital Partners LLC	94,342	$6.24M	0.3%	+12.4%	0.049%
11/6/2024	Mizuho Securities USA LLC	2,000,100	$132.21M	0.3%	+13,814.7%	1.038%
11/6/2024	Kentucky Retirement Systems Insurance Trust Fund	4,733	$0.31M	0.0%	-21.3%	0.002%
11/6/2024	Kentucky Retirement Systems	11,136	$0.74M	0.0%	-20.7%	0.006%
11/6/2024	Empowered Funds LLC	22,081	$1.46M	0.0%	-79.8%	0.011%
11/6/2024	CIBC Asset Management Inc	25,303	$1.67M	0.0%	+2.9%	0.013%

Data available starting January 2016

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $75.87

$73.25

$77.87

50 Day Range

MA: $68.99

$62.26

$83.38

52 Week Range

Now: $75.87

$50.35

$83.95

Volume

3,842,700 shs

Average Volume

2,342,010 shs

Market Capitalization

$14.62 billion

P/E Ratio

541.97

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of Incyte?: Incyte's top insider shareholders include:
Steven H Stein (EVP)
Maria E Pasquale (EVP)
Barry P Flannelly (EVP)
Vijay K Iyengar (EVP)
Jonathan Elliott Dickinson (EVP)
Thomas Tray (Insider)
Learn More about top insider investors at Incyte.
Who are the major institutional investors of Incyte?: Incyte's top institutional investors include:
Baker BROS. Advisors LP — 15.96%
State Street Corp — 5.48%
Geode Capital Management LLC — 2.04%
Point72 Asset Management L.P. — 1.23%
Bellevue Group AG — 1.12%
Mizuho Securities USA LLC — 1.04%
Learn More about top institutional investors of Incyte stock.
Which institutional investors are selling Incyte stock?: During the previous quarter, INCY stock was sold by these institutional investors:
KBC Group NV
Connor Clark & Lunn Investment Management Ltd.
FMR LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Allspring Global Investments Holdings LLC
Caisse DE Depot ET Placement DU Quebec
State Street Corp
ARK Investment Management LLC
In the last year, company insiders that have sold Incyte company stock include:
Steven H Stein (EVP)
Maria E Pasquale (EVP)
Barry P Flannelly (EVP)
Vijay K Iyengar (EVP)
Learn More investors selling Incyte stock.
Which institutional investors are buying Incyte stock?: Within the previous quarter, INCY stock was purchased by institutional investors including:
Point72 Asset Management L.P.
Mizuho Securities USA LLC
Charles Schwab Investment Management Inc.
Bridgewater Associates LP
Point72 Europe London LLP
Barclays PLC
Massachusetts Financial Services Co. MA
Parallax Volatility Advisers L.P.

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad